# OpenAI launches GPT-Rosalind, a new model for biology, drug discovery, and translational medicine.

*biotech · news · 2026-04-18 · The News International*

## Key points

- OpenAI launched GPT-Rosalind, its first domain-specific model for biology and drug discovery tasks.
- GPT-Rosalind achieved the highest BixBench score yet, surpassing all other published models.
- Access to GPT-Rosalind is restricted to qualified US enterprise customers following safety reviews.
- Launch partners include Amgen, Moderna, and Thermo Fisher, with separate research with Los Alamos National Laboratory.
- A free Life Sciences research plugin for Codex is available, linking to over 50 scientific databases.

**Companies:** OpenAI, Amgen, Moderna, Thermo Fisher Scientific
**Countries:** United States, United Kingdom

[Read the full story on The News International](https://www.thenews.com.pk/latest/1399486-openai-gptrosalind-ai-model-to-speed-up-drug-discovery)

---

Canonical: https://newsio.io/n/9a1ad07e-8128-42ac-a13f-fe3bd12cb9ce/openai-launches-gpt-rosalind-a-new-model-for-biology-drug-discovery-and-translat
Summarized by Newsio from The News International. https://newsio.io/how-it-works